Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

about

Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

P2860

Q43167996-B494920B-5BAE-4679-A268-E4723E3329C7

P2860

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

Item

http://www.wikidata.org/entity/Q36326847

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@ast

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@en

type

Item

label

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@ast

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@en

prefLabel

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@ast

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@en

P1476

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

@en

P2093

Breanna R Tercero

http://www.w3.org/2001/XMLSchema#string

Kaori Terasaki

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of glycoprotein C from Rift Valley fever virus

Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)

The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection

Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography

RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses

TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.

A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.

Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors

Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

P304

55-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIRUSRES.2015.05.012

http://www.w3.org/2001/XMLSchema#string

P478

216

http://www.w3.org/2001/XMLSchema#string

P50

Shinji Makino

P577

2015-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26022573

http://www.w3.org/2001/XMLSchema#string

P921

Rift Valley fever phlebovirus

P932

4662630

http://www.w3.org/2001/XMLSchema#string

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

about

P2860

P2860

Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932